Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Roche and Pharmasset to develop new generation HCV therapies

Nov. 2, 2004

Japanese approval for Hepsera

Oct. 29, 2004

Improved nucleoside triphosphate analogue promising against HCV infection

Oct. 27, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

Glycine may represent a novel eradication therapy against drug-resistant H. pylori

Oct. 26, 2004

New HCV studies unveiled for PegIntron in difficult-to-treat populations

Oct. 26, 2004

Japanese approval for PegIntron in combination with Rebetol

Oct. 26, 2004

Positive opinion for Fendrix in Europe

Oct. 26, 2004

Dual opioid receptor agonist JNJ-10335572 shows good activity in in vivo GI assays

Oct. 25, 2004

GSK patent covers new anti-HCV NS5B inhibitors

Oct. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...